polypeptide, purified nucleic acid molecule, vector, host cell, use of a polypeptide, nucleic acid molecule, a vector, or a host cell, pharmaceutical composition, use of a cytokine antagonist or anti-inflammatory agent, use of polypeptide, a nucleic acid molecule, a vector, or a host cell, and a cytokine antagonist or anti-inflammatory agent, a method of treating a disease in a patient, and for identifying a compound and non-transgenic animal human

摘要

"POLYPEPTIDE, PURIFIED NUCLEIC ACID MOLECLE, VECTOR, HOST CELL, USE OF A POLYPEPTIDE, A VECTOR, OR AN HOSPEDIC CELL, ANALYSTAL USE FACTORING, ANALYSTAL USE , A NUCLEIC ACID MOLECLE, A VECTOR, OR A HOST CELL, AND A CYTOKIN ANTAGONIST OR ANTI-INFLAMMATORY AGENT, METHODS OF TREATING A DISEASE IN A PATIENT, AND AN IDENETIC PATIENT Not human". This invention relates to novel uses of a protein sequence (INSP052EC), identified herein as an immunoglobulin domain-containing cell surface recognition, in the diagnosis, prevention and treatment of diseases, particularly those related to expression and / or secretion. excessive cytokines.